3229-0910 Screening compound: 4-[(2E)-2-({4-[(2,4-dichlorophenyl)methoxy]-3-ethoxyphenyl}methylidene)hydrazin-1-yl]-6-(morpholin-4-yl)-N-phenyl-1,3,5-triazin-2-amine

3229-0910 Screening compound: 4-[(2E)-2-({4-[(2,4-dichlorophenyl)methoxy]-3-ethoxyphenyl}methylidene)hydrazin-1-yl]-6-(morpholin-4-yl)-N-phenyl-1,3,5-triazin-2-amine
3229-0910 Screening compound: 4-[(2E)-2-({4-[(2,4-dichlorophenyl)methoxy]-3-ethoxyphenyl}methylidene)hydrazin-1-yl]-6-(morpholin-4-yl)-N-phenyl-1,3,5-triazin-2-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound 3229-0910
4-[(2E)-2-({4-[(2,4-dichlorophenyl)methoxy]-3-ethoxyphenyl}methylidene)hydrazin-1-yl]-6-(morpholin-4-yl)-N-phenyl-1,3,5-triazin-2-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3229-0910

Molecular Formula

C29H29Cl2N7O3 (C29 H29 Cl2 N7 O3)

Compound Name

4-[(2E)-2-({4-[(2,4-dichlorophenyl)methoxy]-3-ethoxyphenyl}methylidene)hydrazin-1-yl]-6-(morpholin-4-yl)-N-phenyl-1,3,5-triazin-2-amine

IUPAC name

4-[(2E)-2-({4-[(24-dichlorophenyl)methoxy]-3-ethoxyphenyl}methylidene)hydrazin-1-yl]-6-(morpholin-4-yl)-N-phenyl-135-triazin-2-amine

SMILES

CCOc(cc(/C=N/Nc1nc(N2CCOCC2)nc(Nc2ccccc2)n1)cc1)c1OCc(ccc(Cl)c1)c1Cl

InChI

InChI=1S/C29H29Cl2N7O3/c1-2-40-26-16-20(8-11-25(26)41-19-21-9-10-22(30)17-24(21)31)18-32-37-28-34-27(33-23-6-4-3-5-7-23)35-29(36-28)38-12-14-39-15-13-38/h3-11,16-18H,2,12-15,19H2,1H3,(H2,33,34,35,36,37)

InChI Key

HSIIDFPBAMWFAR-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01025495

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

594.5

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

7.358

Distribution Coefficient, logD

7.357

Water Solubility, LogSw

-6.65

Polar Surface Area

87.235

Acid Dissociation Constant (pKa)

12.81

Base Dissociation Constant (pKb)

4.80

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

24.10

3229-0910 in Drug Discovery

Included in Screening Libraries

MCL1 Targeted Library (12200 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic

References: we are preparing a list of scientific research reports with 3229-0910 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3229-0910?
Check Price and Availability of 3229-0910, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3229-0910 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3229-0910
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3229-0910
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3229-0910 available by request